BI Asset Management Fondsmaeglerselskab A S Purchases 22,567 Shares of The Clorox Company $CLX

BI Asset Management Fondsmaeglerselskab A S grew its position in shares of The Clorox Company (NYSE:CLX) by 42.1% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 76,232 shares of the company’s stock after purchasing an additional 22,567 shares during the period. BI Asset Management Fondsmaeglerselskab A S’s holdings in Clorox were worth $7,900,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in CLX. Wilkins Investment Counsel Inc. grew its holdings in shares of Clorox by 250.6% during the fourth quarter. Wilkins Investment Counsel Inc. now owns 55,064 shares of the company’s stock worth $5,552,000 after purchasing an additional 39,360 shares in the last quarter. JPMorgan Chase & Co. raised its stake in Clorox by 27.0% in the third quarter. JPMorgan Chase & Co. now owns 928,654 shares of the company’s stock valued at $114,506,000 after purchasing an additional 197,330 shares in the last quarter. Morningstar Investment Management LLC raised its stake in Clorox by 131.8% in the fourth quarter. Morningstar Investment Management LLC now owns 62,454 shares of the company’s stock valued at $6,297,000 after purchasing an additional 35,506 shares in the last quarter. Swiss Life Asset Management Ltd lifted its position in Clorox by 221.4% during the third quarter. Swiss Life Asset Management Ltd now owns 86,426 shares of the company’s stock valued at $10,656,000 after purchasing an additional 59,533 shares during the last quarter. Finally, Birch Hill Investment Advisors LLC purchased a new position in Clorox in the 4th quarter worth approximately $22,103,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Insider Buying and Selling

In related news, Director Pierre R. Breber purchased 5,000 shares of the firm’s stock in a transaction on Tuesday, May 5th. The shares were acquired at an average cost of $85.82 per share, with a total value of $429,100.00. Following the purchase, the director directly owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. 0.63% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of equities analysts have recently commented on CLX shares. Wells Fargo & Company decreased their price target on shares of Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a report on Monday, May 18th. UBS Group dropped their price objective on shares of Clorox from $110.00 to $96.00 and set a “neutral” rating for the company in a report on Friday, May 1st. Zacks Research cut Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, May 12th. Morgan Stanley dropped their price target on Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a research note on Friday, May 1st. Finally, Evercore reiterated an “underperform” rating and issued a $110.00 price objective on shares of Clorox in a report on Friday, May 1st. One equities research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Reduce” and a consensus target price of $103.40.

Clorox Price Performance

Shares of NYSE:CLX opened at $95.90 on Monday. The stock has a market cap of $11.60 billion, a PE ratio of 15.57, a PEG ratio of 0.50 and a beta of 0.56. The company’s fifty day moving average is $95.71 and its 200 day moving average is $104.81. The Clorox Company has a 52 week low of $84.70 and a 52 week high of $132.03. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, topping the consensus estimate of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same period in the previous year, the firm posted $1.45 earnings per share. The firm’s revenue for the quarter was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Research analysts anticipate that The Clorox Company will post 5.61 earnings per share for the current year.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.